Alliancebernstein L.P. Organogenesis Holdings Inc. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 182,690 shares of ORGO stock, worth $675,953. This represents 0.0% of its overall portfolio holdings.
Number of Shares
182,690
Previous 186,270
1.92%
Holding current value
$675,953
Previous $532,000
9.77%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ORGO
# of Institutions
125Shares Held
63.6MCall Options Held
0Put Options Held
500-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$46.2 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$43.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$18.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$13.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$11.4 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $484M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...